विवरण
Antioxidant mechanisms relevant to Alzheimer's disease neuroprotection are summarized, highlighting how reactive oxygen species contribute to neurodegeneration and how antioxidant-loaded delivery systems may counteract oxidative damage.
More Figures from This Paper
Figure 2
Various nanoparticle-based drug delivery systems designed to cross the blood-brain barrier are depicted, including liposomes, polymeric nanoparticles, and solid lipid carriers for Alzheimer's disease therapeutics.
diagram
Figure 4
A comparative overview of different blood-brain barrier crossing strategies is presented, including receptor-mediated transcytosis, adsorptive transcytosis, and focused ultrasound approaches for drug delivery.
diagram
Figure 5
A schematic timeline of Alzheimer's disease progression alongside potential intervention windows for antioxidant and BBB-targeting drug delivery systems is shown, emphasizing early intervention strategies.
diagramFigure 3
DiagramSource Paper
Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems.Cite This Figure
 > Source: Bianca Sânziana Daraban et al. "Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Ba." *Molecules (Basel, Switzerland)*, 2024. PMID: [39274904](https://pubmed.ncbi.nlm.nih.gov/39274904/)
<figure> <img src="https://pdfs.citedhealth.com/figures/39274904/172.png" alt="Antioxidant mechanisms relevant to Alzheimer's disease neuroprotection are summarized, highlighting how reactive oxygen species contribute to neurodegeneration and how antioxidant-loaded delivery systems may counteract oxidative damage." /> <figcaption>Figure 3. Antioxidant mechanisms relevant to Alzheimer's disease neuroprotection are summarized, highlighting how reactive oxygen species contribute to neurodegeneration and how antioxidant-loaded delivery systems may counteract oxidative damage.<br> Source: Bianca Sânziana Daraban et al. "Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Ba." <em>Molecules (Basel, Switzerland)</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39274904/">39274904</a></figcaption> </figure>